Page last updated: 2024-09-03

3-formylrifamycin sv and Tuberculosis, Pulmonary

3-formylrifamycin sv has been researched along with Tuberculosis, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK	1

Trials

1 trial(s) available for 3-formylrifamycin sv and Tuberculosis, Pulmonary

Article	Year
Pharmacokinetics of oral and intravenous rifampicin during chronic administration. Klinische Wochenschrift, 1985, Dec-02, Volume: 63, Issue:23 Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary	1985

Article

Year

Pharmacokinetics of oral and intravenous rifampicin during chronic administration.

Klinische Wochenschrift, 1985, Dec-02, Volume: 63, Issue:23

Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary

1985